34° Curso de Vicenza sobre lesión renal aguda y terapia de reemplazo renal continua: "Alma Mater"

Contenido principal del artículo

Fernando Lombi

Detalles del artículo

Cómo citar
1.
Lombi F. 34° Curso de Vicenza sobre lesión renal aguda y terapia de reemplazo renal continua: "Alma Mater". Rev Nefrol Dial Traspl. [Internet]. 31 de mayo de 2017 [citado 3 de marzo de 2021];36(4):206-10. Disponible en: http://www.revistarenal.org.ar/index.php/rndt/article/view/79
Sección
Editorial

Citas

1) Katz N, Ronco C. Acute kidney stress--a useful term based on evolution in the understanding of acute kidney injury. Crit Care. 2016;20:23.

2) Zarbock A, Kellum JA. Remote ischemic preconditioning and protection of the kidney--a novel therapeutic option. Crit Care Med. 2016;44(3):607-16.

3) Vijayan A, Faubel S, Askenazi DJ, Cerda J, Fissell WH, Heung M, et al. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment. Am J Kidney Dis. 2016;68(1):19-28.

4) Haase M, Müller C, Damman K, Murray PT, Kellum JA, Ronco C, et al. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:99-116.

5) Levante C, Ronco C. The imperative for health economics assessment in acute kidney injury. Blood Purif. 2016;42(2):I-VI.

6) Siew ED, Basu RK, Wunsch H, Shaw AD, Goldstein SL, Ronco C, et al. Optimizing administrative datasets to examine acute kidney injury in the era of big data: workgroup statement from the 15(th) ADQI Consensus Conference. Can J Kidney Health Dis. 2016;3:12.

7) Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKIEPI study. Intensive Care Med. 2015;41(8):1411-23.

8) Vincent JL, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical llness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380-6.

9) Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594-605.

10) Cantaluppi V, Quercia AD, Dellepiane S, Ferrario S, Camussi G, Biancone L. Interaction between systemic inflammation and renal tubular epithelial cells. Nephrol Dial Transplant. 2014;29(11):2004-11.

11) Yang RL, Wang XT, Liu DW, Liu SB. Energy and oxygen metabolism disorder during septic acute kidney injury. Kidney Blood Press Res. 2014;39(4):240-51.

12) Mariano F, Cantaluppi V, Stella M, Romanazzi GM, Assenzio B, Cairo M, et al. Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care. 2008;12(2):R42.

13) Gocze I, Koch M, Renner P, Zeman F, Graf BM, Dahlke MH, et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS One. 2015;10(3):e0120863.

14) Naito M, Bomsztyk K, Zager RA. Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure. J Am Soc Nephrol. 2008;19(7):1321-30.

15) Kimmoun A, Levy B. Angiotensin II: a new approach for refractory shock management? Crit Care. 2014;18(6):694.

16) Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, et al. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care. 2014;18(5):534.

17) Chawla LS, Busse LW, Brasha-Mitchell E, Alotaibi Z. The use of angiotensin II in distributive shock. Crit Care. 2016;20(1):137.

18) Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. N Engl J Med. 2016;375(2):122-33.

19) Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstädt H, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN Randomized Clinical Trial. JAMA. 2016;315(20):2190-9.

20) Wald R, Adhikari NK, Smith OM, Weir MA, Pope K, Cohen A, et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int. 2015;88(4):897-904.

21) Husain-Syed F, Slutsky AS, Ronco C. Lung-kidney cross-talk in the critically ill patient. Am J Respir Crit Care Med. 2016;194(4):402-14.

22) Romay E, Ferrer R. Extracorporeal CO2 removal: Technical and physiological fundaments and principal indications. Med Intensiva. 2016;40(1):33-8.

23) Chen YC, Tsai FC, Fang JT, Yang CW. Acute kidney injury in adults receiving extracorporeal membrane oxygenation. J Formos Med Assoc. 2014;113(11):778-85.

24) Shi J, Chen Q, Yu W, Shen J, Gong J, He C, et al. Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model. Artif Organs. 2014;38(3):215-23.